President Donald Trump signed an executive order Thursday directing federal agencies to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act. This shift acknowledges the drug’s potential medical uses while placing it alongside substances like ketamine and codeine-laced Tylenol, which carry moderate risks of dependence.
READ MORE: Executive High: Trump Reclassifies Marijuana for Health Gains
The move builds on a process initiated under the Biden administration but stalled by inaction for years. Trump emphasized that the order facilitates essential research into marijuana’s benefits and dangers without legalizing recreational use nationwide. “This reclassification order will make it far easier to conduct marijuana-related medical research,” he said during the Oval Office signing, noting its “tremendously positive impact” on…




